Powered by HealthTechMovers.com
We added 2 stocks to our Healthcare & Biotech Stock Watchlist today because they are receiving Bullish Sentiment from investors and financial bloggers.
In addition, they are generating positive media buzz and/or have insider trading signals which came to our attention. This list below is subject to change on a daily basis, so please be sure you subscribe to our email newsletter.
Edwards Lifesciences, EW
Summary: Edwards Lifesciences Corporation provides products and technologies to treat late-stage cardiovascular disease. The Company's products include tissue replacement heart valves, heart valve repair products, hemodynamic monitoring devices, angioscopy equipment, oxygenators, and pharmaceuticals. Edwards Lifesciences Corporation is headquartered in Irvine, California.
- Last Price: 109.49
- Price Change: -1.11, -1.00%
- Yearly Gain: 26.52%
- Market Cap: 68.36B
- P/E Ratio: 46.772
Here are 3rd party ratings for EW:
- TipRanks.com: Strong Buy
- TradingView.com: Sell
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: Weak buy
- Zacks.com: Hold, Bottom 35% (166 out of 254)
What is the sentiment on the street regarding Edwards Lifesciences ? (Current ratings compiled by TipRanks.com)
- News Sentiment: Very Negative
- Blogger Consensus: Bearish
- Media Buzz: High
- Insider Signal: Negative
- Investor Sentiment: Very Negative
- Hedge Fund signal: Negative
If you are interested in EW or any stocks within the Healthcare sector, you might want to click here and check out this report. The stock market is extremely volatile, and you need to do your own research on EW before you decide to make any investment.
Click here for chart >>
Compass Therapeutics, CMPX
Summary: Compass Therapeutics Inc. is a clinical-stage biopharmaceutical company developing proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematologic malignancies. The company's lead product candidate includes CTX-471. Compass Therapeutics Inc. is based in Boston, MA.
- Last Price: 2.07
- Price Change: -0.23, -10.00%
- Yearly Gain: -62.36%
- Market Cap: 202.93M
- P/E Ratio: -1.401
Here are 3rd party ratings for CMPX:
- TipRanks.com: Strong Buy
- TradingView.com: Strong Sell
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: n/a
- Zacks.com: Hold, Bottom 38% (158 out of 254)
What is the sentiment on the street regarding Compass Therapeutics ? (Current ratings compiled by TipRanks.com)
- News Sentiment: Very Negative
- Blogger Consensus: Bearish
- Media Buzz: Very High
- Insider Signal: Negative
- Investor Sentiment: Very Negative
- Hedge Fund signal: No Signal
If you are interested in CMPX or any stocks within the Healthcare sector, you might want to click here and check out this report. The stock market is extremely volatile, and you need to do your own research on CMPX before you decide to make any investment.
Click here for chart >>
Thanks for reading!